Directory
>
Scott Biller
Scott Biller
Board Member | GV (Google Ventures)
Boston, Massachusetts, United States
Scott Biller
Summary
Scott Biller is a seasoned executive in the biotech industry, currently serving as an Executive Venture Partner at GV, where he focuses on innovative investment opportunities in biopharma. With a robust background as the Chief Scientific Officer at Agios Pharmaceuticals, he was pivotal in the discovery of several approved medicines for cancer and metabolic diseases. His extensive experience spans leadership roles at renowned companies like Novartis and Bristol-Myers Squibb, where he contributed to the development of numerous investigational and approved drugs. Scott's academic credentials include a Ph.D. from Caltech and a postdoctoral fellowship at Columbia University, underscoring his strong foundation in organic chemistry. He is also an active board member for several biotech firms, leveraging his expertise to guide the next generation of therapeutic innovations. Awarded the American Chemical Society’s Heroes of Chemistry Award, Scott is recognized for his significant contributions to the field. Residing in Boston, he combines his passion for science with strategic investment to drive advancements in healthcare.
Scott Biller
Work Experience
Board Member at
OMass Therapeutics
January 2022 - Present
Executive Venture Partner at
GV (Google Ventures)
December 2021 - Present
Board Observer at
Gate Bioscience, Inc.
January 2021 - Present
Board Member at
ROME Therapeutics
January 2021 - Present
Board Member at
Foghorn Therapeutics Inc.
January 2020 - Present
Board Member at
Remix Therapeutics
January 2020 - Present
Scientific Advisory Board member at
Vividion
January 2019 - January 2024
Scientific Advisory Board member at
Agios Pharmaceuticals
March 2021 - January 2023
Scientific Advisory Board member at
Denali Therapeutics
January 2015 - January 2023
Strategic Advisor at
Agios Pharmaceuticals
January 2020 - March 2021
Chief Scientific Officer at
Agios Pharmaceuticals
September 2010 - December 2019
Vice President, Global Discovery Chemistry at
Novartis
January 2003 - September 2010
Vice President, Pharmaceutical Candidate Optimization at
Bristol Myers Squibb
June 2001 - July 2003
Director, Executive Director, Discovery Chemistry at
Bristol Myers Squibb
January 1995 - January 2001
Student at
Massachusetts Institute of Technology
January 1972 - January 1976
Scott Biller
Education
Columbia University, Postdoc
January 1982 - January 1983
Caltech, Phd
January 1976 - January 1981
Massachusetts Institute of Technology, Bs
January 1972 - January 1976
Stuyvesant High School, High School Diploma
January 1970 - January 1972
Frequently Asked Questions about Scott Biller
What is Scott Biller email address?
Scott Biller's primary email address is ************@agios.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Scott Biller work for?
Scott Biller is a Board Member at GV (Google Ventures).
Where Scott Biller graduated from?
Scott Biller holds a degree in Organic Chemistry from Columbia University.
How can I directly contact Scott Biller?
To contact Scott Biller directly, you can use the email address ************@agios.com. Complete contact information is available upon registration with Muraena.
Who is Scott Biller?
Scott Biller is a seasoned executive in the biotech industry, currently serving as an Executive Venture Partner at GV, where he focuses on innovative investment opportunities in biopharma. With a robust background as the Chief Scientific Officer at Agios Pharmaceuticals, he was pivotal in the discovery of several approved medicines for cancer and metabolic diseases. His extensive experience spans leadership roles at renowned companies like Novartis and Bristol-Myers Squibb, where he contributed to the development of numerous investigational and approved drugs. Scott's academic credentials include a Ph.D. from Caltech and a postdoctoral fellowship at Columbia University, underscoring his strong foundation in organic chemistry. He is also an active board member for several biotech firms, leveraging his expertise to guide the next generation of therapeutic innovations. Awarded the American Chemical Society’s Heroes of Chemistry Award, Scott is recognized for his significant contributions to the field. Residing in Boston, he combines his passion for science with strategic investment to drive advancements in healthcare.
Scott`s contact details
************@agios.com
************@gv.com
*******@mit.edu
Colleagues
Chief People Officer
General Partner
Chief Financial Officer
Investor | Board Director
Series C Lead & Board Observer
General Partner
General Partner
General Partner
Director
General Partner